{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:36:40Z","timestamp":1789706200905,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.canrad.2016.09.009","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T12:46:37Z","timestamp":1487853997000},"page":"73-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Radiation therapy for malignant pleural mesothelioma"],"prefix":"10.1016","volume":"21","author":[{"given":"K.E.","family":"Rosenzweig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2016.09.009_bib0110","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1067\/mtc.2001.116560","article-title":"A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"122","author":"Rusch","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.canrad.2016.09.009_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.canrad.2016.09.009_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145039","article-title":"Determinants of survival in malignant pleural mesothelioma: a surveillance, epidemiology, and end results (SEER) study of 14,228 patients","volume":"10","author":"Taioli","year":"2015","journal-title":"Plos One"},{"key":"10.1016\/j.canrad.2016.09.009_bib0125","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0360-3016(03)00287-6","article-title":"Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"56","author":"Yajnik","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.09.009_bib0130","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.ijrobp.2007.07.2370","article-title":"Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy","volume":"69","author":"Krayenbuehl","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.09.009_bib0135","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijrobp.2006.03.012","article-title":"Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma","volume":"65","author":"Allen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.09.009_bib0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.radonc.2009.03.011","article-title":"Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"92","author":"Kristensen","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.09.009_bib0145","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ijrobp.2007.11.011","article-title":"Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience","volume":"71","author":"Miles","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.09.009_bib0150","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ijrobp.2007.03.011","article-title":"Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma","volume":"69","author":"Rice","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.09.009_bib0155","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/JTO.0b013e31827740f0","article-title":"Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma","volume":"8","author":"Gomez","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2016.09.009_bib0160","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2011.11.057","article-title":"Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy","volume":"83","author":"Patel","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.09.009_bib0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.radonc.2011.06.040","article-title":"Helical tomotherapy for resected malignant pleural mesothelioma: dosimetric evaluation and toxicity","volume":"101","author":"Giraud","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.09.009_bib0170","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S1470-2045(15)00208-9","article-title":"Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): a randomised, international, multicentre phase 2 trial","volume":"16","author":"Stahel","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2016.09.009_bib0175","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jtcvs.2015.09.129","article-title":"Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"151","author":"de Perrot","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.canrad.2016.09.009_bib0180","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jtcvs.2015.10.038","article-title":"SMART or simply bold?","volume":"151","author":"Rusch","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.canrad.2016.09.009_bib0185","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ijrobp.2005.03.041","article-title":"Hemithoracic radiation therapy after pleurectomy\/decortication for malignant pleural mesothelioma","volume":"63","author":"Gupta","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.09.009_bib0190","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ijrobp.2011.09.027","article-title":"Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma","volume":"83","author":"Rosenzweig","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.09.009_bib0195","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijrobp.2014.05.032","article-title":"Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma","volume":"90","author":"Rimner","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.09.009_bib0200","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/JTO.0b013e318272601f","article-title":"Tomotherapy after pleurectomy\/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung","volume":"7","author":"Minatel","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2016.09.009_bib0205","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1002\/cncr.28875","volume":"120","author":"Hassan","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2016.09.009_bib0210","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1158\/1078-0432.CCR-14-0804","article-title":"Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma","volume":"20","author":"Hassan","year":"2014","journal-title":"Clin Cancer Res"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321817300057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321817300057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:26:37Z","timestamp":1761135997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321817300057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1278321817300057"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2016.09.009","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation therapy for malignant pleural mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2016.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}